- Home
- COCP vs ABP Comparison
COCP vs ABP Comparison
Compare COCP & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- ABP
- Stock Information
- Founded
- COCP 2006
- ABP 2004
- Country
- COCP United States
- ABP United States
- Employees
- COCP N/A
- ABP N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- COCP Health Care
- ABP Health Care
- Exchange
- COCP Nasdaq
- ABP Nasdaq
- Market Cap
- COCP 15.4M
- ABP 17.2M
- IPO Year
- COCP N/A
- ABP N/A
- Fundamental
- Price
- COCP $1.22
- ABP $0.20
- Analyst Decision
- COCP Strong Buy
- ABP Strong Buy
- Analyst Count
- COCP 1
- ABP 1
- Target Price
- COCP $6.00
- ABP $4.00
- AVG Volume (30 Days)
- COCP 4.6M
- ABP 5.4M
- Earning Date
- COCP 11-12-2025
- ABP 11-18-2025
- Dividend Yield
- COCP N/A
- ABP N/A
- EPS Growth
- COCP N/A
- ABP N/A
- EPS
- COCP N/A
- ABP N/A
- Revenue
- COCP N/A
- ABP $183,000.00
- Revenue This Year
- COCP N/A
- ABP N/A
- Revenue Next Year
- COCP N/A
- ABP N/A
- P/E Ratio
- COCP N/A
- ABP N/A
- Revenue Growth
- COCP N/A
- ABP 154.17
- 52 Week Low
- COCP $1.12
- ABP $0.15
- 52 Week High
- COCP $3.26
- ABP $11.19
- Technical
- Relative Strength Index (RSI)
- COCP 37.81
- ABP 43.99
- Support Level
- COCP $1.17
- ABP $0.21
- Resistance Level
- COCP $1.31
- ABP $0.28
- Average True Range (ATR)
- COCP 0.09
- ABP 0.03
- MACD
- COCP -0.00
- ABP 0.00
- Stochastic Oscillator
- COCP 20.00
- ABP 16.45
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.